IAM

Recent UK decision in epic Neurim v Mylan patent battle may benefit generics seeking to stay injunctions

The country's courts continue to show great flexibility in an unusual dispute involving insomnia treatment Circadin

08 April 2022

English Court of Appeal brings sufficiency test into line with EPO case law

A recent UK judgment is good news for owners of patents claiming large numbers of compounds

07 September 2021

The state of play for SEPs in Europe's major jurisdictions

A country-by-country analysis warns of uneven ground in the standards landscape

29 November 2019

All eyes turn to London as UK Supreme Court mulls SEP FRAND cases

How the appeals brought by Huawei and ZTE could upend the licensing market

29 November 2019

Trespassing prohibited

The availability of injunctive relief varies widely around the world. In our first analysis of the global injunction landscape we lift the lid on which jurisdictions provide the best opportunity for a sales ban

30 August 2019

UK judge reins in ZTE’s China counter-suit against Conversant

But IAM research shows the NPE led by Boris Teksler is facing a barrage of Chinese invalidity actions from both ZTE and its co-defendant Huawei.

09 October 2018